News | May 07, 2026
Novo Nordisk posts strong Q1 as Wegovy drives global GLP-1 momentum
The standout story remains Wegovy, particularly its new oral formulation
The standout story remains Wegovy, particularly its new oral formulation
The pharmaceutical giant reported $14.5 billion in revenue, up 5% year-over-year, and reaffirmed its full-year outlook
Doctors highlight rising respiratory risks linked to pollution, seasonal changes, and poor treatment adherence amid increasing asthma burden in India
Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures
New facility at Pusa Road expands advanced diagnostic, theranostics, and treatment-planning capabilities across oncology, cardiology, neurology, and nephrology
India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
The company’s Growth Portfolio delivered $6.2 billion in revenue
Leading orthopaedic experts call for equitable insurance coverage to patients for accessing advanced, precision-driven joint replacement technologies
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
